Mo1847 - Reactive Dose Escalation of Infliximab in Patients with Crohn's Disease in Tailorix Leads to Improved Outcomes
2018 ◽
Vol 12
(supplement_1)
◽
pp. S396-S397
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
2017 ◽
Vol 2
(4)
◽
pp. 228-235
◽
Keyword(s):
2014 ◽
Vol 20
(1)
◽
pp. 214
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 3
(1)
◽
pp. 29229
◽